Telemus Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$703K	Buy	800 +1	+0.1%	+$823	0.06%	196
2023 Q3	$658K	Sell	799 -3	-0.4%	-$2.36K	0.06%	192
2023 Q2	$576K	Buy	802 +221	+38%	+$170K	0.05%	209
2023 Q1	$477K	Sell	581 -21	-3%	-$15.8K	0.04%	221
2022 Q4	$444K	Buy	602 +29	+5%	+$21.4K	0.04%	234
2022 Q3	$395K	Hold	573	–	–	0.04%	224
2022 Q2	$339K	Buy	573 +202	+54%	+$131K	0.03%	269
2022 Q1	$259K	Buy	371 +6	+2%	+$3.8K	0.02%	298
2021 Q4	$231K	Sell	365 -2	-0.5%	-$1.23K	0.02%	341
2021 Q3	$222K	Sell	367 -1,213	-77%	-$753K	0.02%	319
2021 Q2	$882K	Buy	1,580 +150	+10%	+$76K	0.06%	184
2021 Q1	$693K	Buy	1,430 +570	+66%	+$278K	0.05%	241
2020 Q4	$415K	Sell	860 -707	-45%	-$382K	0.03%	279
2020 Q3	$940K	Buy	1,567 +995	+174%	+$603K	0.07%	202
2020 Q2	$355K	Hold	572	–	–	0.03%	319
2020 Q1	$351K	Buy	+572	New	+$236K	0.03%	293
2018 Q1	–	Sell	-40	Closed	-$15K	–	520
2017 Q4	$15K	Sell	40 -4,004	-99%	-$1.62M	﹤0.01%	487
2017 Q3	$1.81M	Hold	4,044	–	–	0.21%	88
2017 Q2	$1.99M	Buy	+4,044	New	+$1.77M	0.2%	85